Cite
HARVARD Citation
Barratt, J. et al. (n.d.). MO212: Updated Interim Results of A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of BION-1301 in Patients With IGA Nephropathy. Nephrology dialysis transplantation. p. . [Online].